PALIPERIDONE EXTENDED-RELEASE TABLETS, 9 mg, 100 Tablets per carton (10 x 10 blister packs), Rx o...

FDA Recall #D-0649-2022 — Class II — February 28, 2022

Recall #D-0649-2022 Date: February 28, 2022 Classification: Class II Status: Terminated

Product Description

PALIPERIDONE EXTENDED-RELEASE TABLETS, 9 mg, 100 Tablets per carton (10 x 10 blister packs), Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191, India. Distributed by: MAJOR PHARMACEUTICALS, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152. NDC: 0904-6937-61

Reason for Recall

Failed Dissolution Specifications

Recalling Firm

The Harvard Drug Group — Livonia, MI

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

174 cartons

Distribution

Nationwide within the United States

Code Information

Lot #: N00522, Exp. Date 09/2022; N00618, Exp. Date 11/2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated